麻醉医师控制与患者自控效应室靶控丙泊酚镇静在腰麻下择期初次下肢关节置换术中的比较(ACCEPTS):平行组随机对照试验研究方案
本研究为开放标签、随机对照优效性试验,旨在比较效应室靶控患者自控丙泊酚镇静(PMPS)与麻醉医师控制丙泊酚镇静(ACPS)在腰麻下择期初次下肢关节置换术中的临床效能,主要研究目标是比较两组按体重归一化的丙泊酚消耗速率,并收集原型PMPS装置的安全性数据。
要点
- 首次比较效应室靶控PMPS与ACPS在关节置换术中的丙泊酚消耗速率。
- 研究采用开放标签、随机对照优效性设计,招募腰麻下择期初次下肢关节置换术成人患者。
- 主要结局为按体重归一化的丙泊酚消耗速率,并评估原型装置的安全性。
核心结论
- 效应室靶控患者自控丙泊酚镇静与麻醉医师控制镇静在腰麻下关节置换术中的临床效能尚不清楚,本试验将比较两者按体重归一化的丙泊酚消耗速率。
研究设计与样本
- 开放标签、随机对照优效性试验,招募腰麻下择期初次下肢关节置换术成人患者,随机分为PMPS和ACPS两个等量平行组。
关键数值与推荐
- 主要研究目标为比较PMPS与ACPS两组按体重归一化的丙泊酚消耗速率。
- 主要无效假设为患者自控与麻醉医师控制的丙泊酚消耗速率无差异。
临床怎么用
- 试验结果将帮助临床医生和装置制造商了解患者自控丙泊酚镇静在常见手术场景中的临床效能和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical efficacy of effect-site targeted patient-maintained propofol sedation (PMPS) compared to anaesthetist-controlled propofol sedation (ACPS) for patients undergoing awake joint replacement surgery is currently unknown. There is no commercially available medical device capable of delivering PMPS so we have designed and built such a device. We plan a clinical trial to compare PMPS to ACPS and to collect data relating to the safety of our prototype device in delivering sedation. METHODS: The trial is an open-label, randomised, controlled superiority trial recruiting adults who are undergoing elective primary lower-limb arthroplasty with sedation by propofol infusion by effect-site targeting into two equal-sized parallel arms: PMPS and ACPS. The primary research objective is to compare the body-weight-normalised rate of propofol consumption when sedation for surgery on adults undergoing elective primary lower-limb arthroplasty under spinal anaesthesia is patient-maintained versus when it is anaesthetist-controlled. The study primary null hypothesis is that there is no difference in the rate of propofol consumption when sedation is patient-maintained versus anaesthetist-controlled. DISCUSSION: This is the first trial to test the superiority of effect-site-targeted patient-maintained propofol sedation versus anaesthetist-controlled propofol sedation in terms of total propofol consumption during the sedation period. The results of this trial will help inform clinicians and device manufacturers of the clinical efficacy and safety of patient-maintained propofol sedation applied to a common operative setting. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number Registry, ISRCTN29129799 . Prospectively registered on 12 June 2018.
引用
- Hewson DW, Worcester F, Sprinks J, et al. Anaesthetist-controlled versus patient-maintained effect-site targeted propofol sedation during elective primary lower-limb arthroplasty performed under spinal anaesthesia (ACCEPTS): study protocol for a parallel-group randomised comparison trial. Trials. 2019. PMID: 30760311. doi:10.1186/s13063-019-3228-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。